Nuclear data from AMS & nuclear data for AMS - some examples

We summarize some recent cross-section measurements using accelerator mass spectrometry (AMS). AMS represents an ultra-sensitive technique for measuring a limited, but steadily increasing number of longer-lived radionuclides. This method implies a two-step procedure with sample activation and subsequent AMS measurement. Applications include nuclear astrophysics, nuclear technology (nuclear fusion, nuclear fission and advanced reactor concepts and radiation dose estimations). A series of additional applications involves cosmogenic radionuclides in environmental, geological and extraterrestrial studies. Lack of information exists for a list of nuclides as pointed out by nuclear data requests. An overview of some recent measurements is given and the method is exemplified for some specific neutron-induced reactions.JRC.D.4-Standards for Nuclear Safety, Security and Safeguard

Towards a More Complete and Accurate Experimental Nuclear Reaction Data Library (EXFOR): International Collaboration Between Nuclear Reaction Data Centres (NRDC)

The International Network of Nuclear Reaction Data Centres (NRDC) coordinated by the IAEA Nuclear Data Section (NDS) is successfully collaborating in the maintenance and development of the EXFOR library. As the scope of published data expands (e.g., to higher energy, to heavier projectile) to meet the needs from the frontier of sciences and applications, it becomes nowadays a hard and challenging task to maintain both completeness and accuracy of the whole EXFOR library. The paper describes evolution of the library with highlights on recent developments.Comment: 4 pages, 2 figure

Blockade of VEGFR1 and 2 Suppresses Pathological Angiogenesis and Vascular Leakage in the Eye

VEGFR1 and 2 signaling have both been increasingly shown to mediate complications of ischemic retinopathies, including retinopathy of prematurity (ROP), age-related macular degeneration (AMD), and diabetic retinopathy (DR). This study evaluates the effects of blocking VEGFR1 and 2 on pathological angiogenesis and vascular leakage in ischemic retinopathy in a model of ROP and in choroidal neovascularization (CNV) in a model of AMD.H]-mannitol leakage from blood vessels into the retina. Gene expression was measured by real-time quantitative (Q)PCR.VEGFR1 and VEGFR2 expressions were up-regulated during CNV pathogenesis. Both MF1 and DC101 significantly suppressed CNV at 50 mg/kg: DC101 suppressed CNV by 73±5% (p<0.0001) and MF1 by 64±6% (p = 0.0002) in a dosage-dependent manner. The combination of MF1 and DC101 enhanced the inhibitory efficacy and resulted in an accumulation of retinal microglia at the CNV lesion. Similarly, both MF1 and DC101 significantly suppressed retinal NV in OIR at 50 mg/kg: DC101 suppressed retinal NV by 54±8% (p = 0.013) and MF1 by 50±7% (p<0.0002). MF1 was even more effective at inhibiting ischemia-induced BRB breakdown than DC101: the retina/lung leakage ratio for MF1 was reduced by 73±24%, p = 0.001 and for DC101 by 12±4%, p = 0.003. The retina/renal leakage ratio for MF1 was reduced by 52±28%, p = 0.009 and for DC101 by 13±4%, p = 0.001.Our study provides further evidence that both VEGFR1 and 2 mediate pathological angiogenesis and vascular leakage in these models of ocular disease and suggests that antagonist antibodies to these receptor tyrosine kinases (RTKs) are potential therapeutic agents

Space Shuttle drops down the SAA doses on ISS

Long-term analysis of data from two radiation detection instruments on the International Space Station (ISS) shows that the docking of the Space Shuttle drops down the measured dose rates in the region of the South Atlantic Anomaly (SAA) by a factor of 1.5–3. Measurements either by the R3DE detector, which is outside the ISS at the EuTEF facility on the Columbus module behind a shielding of less than 0.45 g cm-², and by the three detectors of the Liulin-5 particle telescope, which is inside the Russian PEARS module in the spherical tissue equivalent phantom behind much heavier shielding demonstrate that effect. Simultaneously the estimated averaged incident energies of the incoming protons rise up from about 30 to 45 MeV. The effect is explained by the additional shielding against the SAA 30–150 MeV protons, provided by the 78 tons Shuttle to the instruments inside and outside of the ISS. An additional reason is the ISS attitude change (performed for the Shuttle docking) leading to decreasing of dose rates in two of Liulin-5 detectors because of the East–West proton fluxes asymmetry in SAA. The Galactic Cosmic Rays dose rates are practically not affected

Nuclear Data from AMS & Nuclear Data for AMS – some examples

We summarize some recent cross-section measurements using accelerator mass spectrometry (AMS). AMS represents an ultra-sensitive technique for measuring a limited, but steadily increasing number of longer-lived radionuclides. This method implies a two-step procedure with sample activation and subsequent AMS measurement. Applications include nuclear astrophysics, nuclear technology (nuclear fusion, nuclear fission and advanced reactor concepts and radiation dose estimations). A series of additional applications involves cosmogenic radionuclides in environmental, geological and extraterrestrial studies. There is a lack of information for a list of nuclides, as pointed out by nuclear data requests. An overview of some recent measurements is given and the method is illustrated for some specific neutron-induced reactions